Skip to main content

Medicine by machine: Is A.I. the cure for the world's ailing drug industry?

By Fortune  
   January 21, 2020

When a Canadian company called Deep Genomics announced in September that it had used artificial intelligence to solve a long-standing mystery about a genetic disorder called Wilson’s disease—and, what’s more, had used another deep-learning platform to identify a potential treatment—there was a flurry of excitement in the drug development world.

Full story

Get the latest on healthcare leadership in your inbox.